Fluid Intolerance Signals as Safety Limits to Prevent Fluid-induced Harm During Septic Shock Resuscitation

Recruiting N/A Interventional Study
Septic Shock
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
62 (estimated)
Sponsor
Pontificia Universidad Catolica de Chile · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this multicentric randomized controlled trial is to compare, in septic shock patients who require further fluid resuscitation, two strategies of administering fluids. The intervention group will integrate fluid intolerance signals to the decision making process, while the control group will follow standard of care, for a 6 hour study protocol. The main question it aims to answer is 1.…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosed or suspected septic shock * \< 24 hours since diagnosis * Hypoperfusion signal (altered arterial lactate or CRT) that requires further resuscitation * Mechanical ventilation * Positive fluid responsiveness status Exclusion Criteria: * Pregnancy * Do-not-resuscitate…
Contacts

Eduardo Kattan, MD, PhD

+56223543292

e.kattan@gmail.com

CONTACT

Ricardo Castro, MD

+56223543292

rcastro.med@gmail.com

CONTACT